{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/contraception-ius-iud/","result":{"data":{"firstChapter":{"id":"fa63ff86-38d1-5d04-b121-e6ba3a5b60d3","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field 46c4d378-e073-45e1-92de-aa1400f86c8e --><h1>Contraception - IUS/IUD: Summary</h1><!-- end field 46c4d378-e073-45e1-92de-aa1400f86c8e -->","htmlStringContent":"<!-- begin item 24cb0f0d-0371-42b0-a2b6-5c8c0ce51d0b --><!-- begin field 801558a0-dd03-4407-b4aa-e667005561c2 --><ul><li>Intrauterine contraception (IUC) methods are long-acting reversible contraceptives (LARCs) with licensed durations of use ranging between 3–10 years, depending on the device chosen. </li><li>The two types of IUC currently available in the UK are:<ul><li>The levonorgestrel intrauterine system (LNG-IUS).</li><li>The copper intrauterine device (Cu-IUD). </li></ul></li><li>The LNG-IUS acts mainly via its progestogenic effect on the endometrium, which prevents implantation of the fertilized ovum. Changes in cervical mucus also inhibit the penetration of sperm into the uterus.<ul><li>When used perfectly (consistently and correctly), 0.2% of women will conceive within the first year of use due to method failure.</li><li>When used typically, 0.2% of women will conceive within the first year of use due to method failure.</li></ul></li><li>The Cu-IUD inhibits fertilization by its toxic effect on sperm and ova. If fertilization does occur, the Cu-IUD has an anti-implantation effect.<ul><li>When used perfectly (consistently and correctly), 0.6% of women will conceive within the first year of use due to method failure.</li><li>When used typically, 0.8% of women will conceive within the first year of use due to method failure or user failure.</li></ul></li><li>Risks and adverse effects of IUC include: <ul><li>Pain on insertion.</li><li>Expulsion of the device.</li><li>Unscheduled bleeding. </li><li>Perforation of the uterine wall at the time of insertion or later.</li><li>Pelvic inflammatory disease.</li><li>Ectopic pregnancy.</li><li>Weight gain.</li><li>For the LNG-IUS — acne, breast tenderness, headache, and ovarian cysts.</li></ul></li><li>IUC should only be inserted by trained and accredited healthcare professionals.<ul><li>A full medical and sexual history should be taken to assess the woman's suitability for use of the method and the woman's risk of sexually transmitted infections (STIs). </li><li>Information on the IUC should be given to the woman, including information on the efficacy, advantages and disadvantages, possible risks and adverse effects, and what to do if she is unable to feel the threads. </li><li>Pregnancy should be excluded before the IUC is inserted. The use of a barrier method of contraception (such as condoms) should be advised until pregnancy can be excluded.</li></ul></li></ul><!-- end field 801558a0-dd03-4407-b4aa-e667005561c2 --><!-- end item 24cb0f0d-0371-42b0-a2b6-5c8c0ce51d0b -->","topic":{"id":"5fd4f695-2824-524f-97fd-1ffbc1ed1ad6","topicId":"14c8f64d-295a-4e1a-92b1-5280c3cce30f","topicName":"Contraception - IUS/IUD","slug":"contraception-ius-iud","aliases":[],"chapters":[{"id":"fa63ff86-38d1-5d04-b121-e6ba3a5b60d3","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"a6a86d04-8f24-5c92-b340-fe91a3323c4f","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"841f70dc-d28e-5fb0-a68a-d6dac27e0ffb","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"5c7dee41-86ab-5d74-b647-984a7323f97c","slug":"changes","fullItemName":"Changes"},{"id":"24837e86-76a3-581e-ae6a-b827bf3bd948","slug":"update","fullItemName":"Update"}]},{"id":"abaf741b-ff01-59e1-8db9-510b749e87b7","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"b6f49269-86ef-5810-8059-10d065f377f0","slug":"goals","fullItemName":"Goals"},{"id":"a95a933e-1a31-5be4-9009-21b8a79da2ae","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"defba0ce-4495-5c71-8bfb-d04ee36d79e9","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"f24f3c36-9720-5dd2-a7c5-8552fd694e1c","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"ff8474b0-1358-5b27-8928-58d81c1aeb7a","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - options for local implementation"},{"id":"f10c46df-f19e-51c2-bd07-c680f266f212","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"7a441ab2-b820-5821-8c27-5a2e71c741aa","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"c7698130-9973-5145-aa0e-981a48972d36","slug":"definition","fullItemName":"Definition"},{"id":"9dbc8287-ded7-50ad-a43e-d87edeebb462","slug":"types","fullItemName":"Types"},{"id":"35c8bc48-3518-55a7-ae5a-a86db3ff3a56","slug":"mode-of-action","fullItemName":"Mode of action"},{"id":"aab10d36-adb8-52f6-895c-f7ce73e2ef4c","slug":"efficacy","fullItemName":"Efficacy"},{"id":"91843ac0-bc35-5798-b0e9-da4d52b30a69","slug":"advantages-disadvantages","fullItemName":"Advantages and disadvantages"},{"id":"6058a967-a6d7-52cd-9cf5-d2d480ec4d7d","slug":"where-to-obtain","fullItemName":"Where to obtain"}]},{"id":"98bf4d7c-c4c4-5c19-9821-a8c43bb9b0fe","slug":"management","fullItemName":"Management","subChapters":[{"id":"3aef47bd-6fd3-5fc1-a254-61098a484a64","slug":"levonorgestrel-intrauterine-system","fullItemName":"Scenario: Levonorgestrel intrauterine system"},{"id":"52ed621a-9a40-532d-ac51-ba401911db84","slug":"copper-intrauterine-device","fullItemName":"Scenario: Copper intrauterine device"}]},{"id":"08730ed3-ce27-5f45-b6fa-9747b4d35a64","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"cfebd8c6-03b3-541a-8425-4f73a4eafe81","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"23a8e2fd-3eac-5088-919c-f81757e13399","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"0f38e730-f213-59fe-afba-bf3f2f2b92e1","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"64158eb2-3052-5f75-872c-1f839e443457","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"a8fc3514-5b7d-55bb-a8d1-c58fb846dde6","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"71aff73b-554d-5df3-b36c-cc7490291d7f","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"fb77b532-9628-57cb-a96d-9533a61e730c","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"5fd4f695-2824-524f-97fd-1ffbc1ed1ad6","topicId":"14c8f64d-295a-4e1a-92b1-5280c3cce30f","topicName":"Contraception - IUS/IUD","slug":"contraception-ius-iud","aliases":[],"topicSummary":"Intrauterine contraceptives (IUCs) are long-acting reversible contraceptives (LARCs) which have a licensed duration of use of 310 years","lastRevised":"Last revised in February 2021","nextPlannedReviewBy":"2026-02-01T00:00:00+00:00","nextPlannedReviewByDateTime":"2026-02","nextPlannedReviewByDisplay":"February 2026","specialities":[{"id":"36359dab-3569-558a-9136-fb7dcb5a1827","name":"Pregnancy","slug":"pregnancy"},{"id":"f05d0400-7348-5229-ab3e-400d91618189","name":"Sexual health","slug":"sexual-health"},{"id":"0c813417-9691-5826-9371-c4bec6c53f06","name":"Women's health","slug":"womens-health"}],"chapters":[{"id":"fa63ff86-38d1-5d04-b121-e6ba3a5b60d3","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"a6a86d04-8f24-5c92-b340-fe91a3323c4f","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"841f70dc-d28e-5fb0-a68a-d6dac27e0ffb","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"5c7dee41-86ab-5d74-b647-984a7323f97c","slug":"changes","fullItemName":"Changes"},{"id":"24837e86-76a3-581e-ae6a-b827bf3bd948","slug":"update","fullItemName":"Update"}]},{"id":"abaf741b-ff01-59e1-8db9-510b749e87b7","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"b6f49269-86ef-5810-8059-10d065f377f0","slug":"goals","fullItemName":"Goals"},{"id":"a95a933e-1a31-5be4-9009-21b8a79da2ae","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"defba0ce-4495-5c71-8bfb-d04ee36d79e9","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"f24f3c36-9720-5dd2-a7c5-8552fd694e1c","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"ff8474b0-1358-5b27-8928-58d81c1aeb7a","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - options for local implementation"},{"id":"f10c46df-f19e-51c2-bd07-c680f266f212","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"7a441ab2-b820-5821-8c27-5a2e71c741aa","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"c7698130-9973-5145-aa0e-981a48972d36","slug":"definition","fullItemName":"Definition"},{"id":"9dbc8287-ded7-50ad-a43e-d87edeebb462","slug":"types","fullItemName":"Types"},{"id":"35c8bc48-3518-55a7-ae5a-a86db3ff3a56","slug":"mode-of-action","fullItemName":"Mode of action"},{"id":"aab10d36-adb8-52f6-895c-f7ce73e2ef4c","slug":"efficacy","fullItemName":"Efficacy"},{"id":"91843ac0-bc35-5798-b0e9-da4d52b30a69","slug":"advantages-disadvantages","fullItemName":"Advantages and disadvantages"},{"id":"6058a967-a6d7-52cd-9cf5-d2d480ec4d7d","slug":"where-to-obtain","fullItemName":"Where to obtain"}]},{"id":"98bf4d7c-c4c4-5c19-9821-a8c43bb9b0fe","slug":"management","fullItemName":"Management","subChapters":[{"id":"3aef47bd-6fd3-5fc1-a254-61098a484a64","slug":"levonorgestrel-intrauterine-system","fullItemName":"Scenario: Levonorgestrel intrauterine system"},{"id":"52ed621a-9a40-532d-ac51-ba401911db84","slug":"copper-intrauterine-device","fullItemName":"Scenario: Copper intrauterine device"}]},{"id":"08730ed3-ce27-5f45-b6fa-9747b4d35a64","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"cfebd8c6-03b3-541a-8425-4f73a4eafe81","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"23a8e2fd-3eac-5088-919c-f81757e13399","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"0f38e730-f213-59fe-afba-bf3f2f2b92e1","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"64158eb2-3052-5f75-872c-1f839e443457","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"a8fc3514-5b7d-55bb-a8d1-c58fb846dde6","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"71aff73b-554d-5df3-b36c-cc7490291d7f","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"fb77b532-9628-57cb-a96d-9533a61e730c","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"5fd4f695-2824-524f-97fd-1ffbc1ed1ad6"}},"staticQueryHashes":["3666801979"]}